West Face Capital

West Face Capital is a Toronto-based alternative investment management firm founded in 2006 by Gregory Boland. The firm specializes in event-driven, distressed, and opportunistic investments across various industries, including healthcare, energy, and telecommunications. Within the life sciences sector, West Face is primarily recognized for its role as a significant activist investor in specialty pharmaceutical companies, most notably Concordia International (now Advanz Pharma). Historically one of Canada's leading hedge funds, the firm has more recently focused on resolving complex legal challenges following a high-profile multi-year conflict with The Catalyst Capital Group. For a biotech analyst, the firm represents a notable example of how activist capital can influence the strategic direction and valuation of mid-cap pharmaceutical entities.